Ingalls & Snyder LLC Gsk PLC Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $115,637 - $131,367	-2,750 Reduced 4.23%	62,201 $2.71 Million
Q1 2022 May 09, 2022	SELL	$40.23 - $47.74 $100,574 - $119,350	-2,500 Reduced 3.71%	64,951 $2.83 Million
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $132,969 - $154,960	-3,420 Reduced 4.83%	67,451 $2.98 Million
Q3 2021 Oct 27, 2021	SELL	$38.79 - $43.16 $266,526 - $296,552	-6,871 Reduced 8.84%	70,871 $2.71 Million
Q2 2021 Aug 03, 2021	SELL	$36.52 - $41.46 $69,388 - $78,774	-1,900 Reduced 2.39%	77,742 $3.1 Million
Q1 2021 Apr 21, 2021	BUY	$34.27 - $40.01 $1,713 - $2,000	50 Added 0.06%	79,642 $2.84 Million
Q4 2020 Jan 27, 2021	SELL	$34.07 - $39.94 $95,464 - $111,911	-2,802 Reduced 3.4%	79,592 $2.93 Million
Q3 2020 Oct 21, 2020	BUY	$38.11 - $42.99 $272,486 - $307,378	7,150 Added 9.5%	82,394 $3.1 Million
Q2 2020 Jul 31, 2020	SELL	$37.87 - $43.58 $49,231 - $56,654	-1,300 Reduced 1.7%	75,244 $3.07 Million
Q1 2020 Apr 22, 2020	BUY	$32.47 - $48.83 $29,223 - $43,947	900 Added 1.19%	76,544 $2.9 Million
Q4 2019 Jan 15, 2020	BUY	$42.0 - $48.25 $276,864 - $318,064	6,592 Added 9.55%	75,644 $3.56 Million
Q3 2019 Oct 16, 2019	SELL	$40.46 - $43.52 $18,004 - $19,366	-445 Reduced 0.64%	69,052 $2.95 Million
Q2 2019 Jul 11, 2019	BUY	$39.4 - $42.7 $14,775 - $16,012	375 Added 0.54%	69,497 $2.78 Million
Q1 2019 Apr 11, 2019	BUY	$38.57 - $42.69 $21,213 - $23,479	550 Added 0.8%	69,122 $2.89 Million
Q4 2018 Jan 24, 2019	SELL	$37.8 - $42.69 $20,827 - $23,522	-551 Reduced 0.8%	68,572 $2.62 Million
Q3 2018 Oct 24, 2018	BUY	$39.75 - $42.69 $622,445 - $668,482	15,659 Added 29.29%	69,123 $2.78 Million
Q2 2018 Aug 10, 2018	BUY	$39.61 - $42.76 $25,548 - $27,580	645 Added 1.22%	53,464 $2.16 Million
Q1 2018 Apr 17, 2018	BUY	$36.18 - $40.15 $49,747 - $55,206	1,375 Added 2.67%	52,819 $2.06 Million
Q4 2017 Jan 19, 2018	SELL	$35.34 - $41.9 $257,487 - $305,283	-7,286 Reduced 12.41%	51,444 $1.83 Million
Q3 2017 Oct 20, 2017	BUY	$39.44 - $41.55 $2.32 Million - $2.44 Million	58,730	58,730 $2.38 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account